Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational studyMagnus Unemo, Alison Luckey, Esther Bettiol et al.|The Lancet Microbe|2026Cited by 4
646. Subgroup Analyses of Microbiological Cure Rates by Baseline Zoliflodacin MIC and Susceptibility to Ciprofloxacin in Participants from the Global Zoliflodacin Phase 3 Randomized Controlled TrialSarah M. McLeod, Alison Luckey, Khurram Rana et al.|Open Forum Infectious Diseases|2026Cited by 1
P-1103. In Vitro Activity of Zoliflodacin Against Baseline <i>Neisseria gonorrhoeae</i> Isolates from US Participants in a Global Phase 3 Randomized Controlled TrialSarah M. McLeod, Alison Luckey, Esther Bettiol et al.|Open Forum Infectious Diseases|2025Cited by 0
P-1206. Association of Sex Assigned at Birth and Sexual Orientation with Antimicrobial Susceptibility of Baseline Neisseria gonorrhoeae Isolates from Participants Recruited in the Global Zoliflodacin Phase 3 Randomized Controlled TrialSarah M. McLeod, Alison Luckey, Drew Lewis et al.|Open Forum Infectious Diseases|2026Cited by 0